Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19

NCT04876573 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Viral Pneumonia
COVID-19 Pneumonia
Serotonin Syndrome
Platelet Dysfunction

Interventions

DRUG: Cyproheptadine Hydrochloride 4 MG

Sponsor

Ciusss de L'Est de l'Île de Montréal